A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and the Decline in Kidney Function in Participants with Body Mass Index ≥27 kg/m2 and Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date28/05/24 → 28/05/29

Keywords

  • clinical trial
  • Atherosclerotic Cardiovascular Disease
  • Chronic Kidney Disease
  • body mass index